Justice makes arrests in $2.1B healthcare scheme

Thirty-five defendants have been charged by the Department of Justice in a Medicare fraud case worth more than $2.1 billion. The healthcare fraud case is one of the biggest ever charged.

The case involved fraudulent genetic testing across dozens of telemedicine companies and cancer genetic testing laboratories, charging CEOs, CFOs and others. The DOJ worked with HHS and FBI. CMS’ Center for Program Integrity (CMS/CPI) also announced administrative action against cancer genetic testing companies and medical professionals for $.17 billion in Medicare claims.

The fraud scheme involved illegal kickbacks and bribes by cancer genetic testing labs in exchange for Medicare beneficiary referrals from medical professionals working with fraudulent telemedicine companies. These tests were expensive and medically unnecessary.

In some cases, the tests were “worthless” to the beneficiaries’ doctors or weren’t performed at all, according to the DOJ. Allegedly, hundreds of thousands of elderly and disabled patients were lured into the network by the defendants.

“These defendants allegedly duped Medicare beneficiaries into signing up for unnecessary genetic tests, costing Medicare billions of dollars,” Assistant Attorney General Brian A. Benczkowski of the Justice Department’s Criminal Division said in a statement. “Together with our law enforcement partners, the Department will continue to protect the public fisc and prosecute those who steal our taxpayer dollars.”

The DOJ announced charges against defendants in Florida, Louisiana, Georgia, Texas and New Jersey.

“Unfortunately, audacious schemes such as those alleged in the indictments are pervasive and exploit the promise of new medical technologies such as genetic testing and telemedicine for financial gain, not patient care,” Deputy Inspector General for Investigations Gary L. Cantrell of HHS-OIG, said in a statement.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”